National Drug Abuse Treatment 

  PROTOCOL NIDA-CTN-0027-A-2


Retention of Suboxone Patients in START: Perspectives of Providers and Patients

Yih-Ing Hser, PhD
Lead Investigator
Integrated Substance Abuse Programs
University of California, Los Angeles
ysher@ucla.edu

This ancillary study is related to CTN-0027, "Starting Treatment with Agonist Replacement Therapies (START)."

The overall purposes of the supplemental study are (1) to identify barriers for retaining Suboxone patients in START, and (2) to address the barriers if study conditions and findings permit.

RELATED STUDIES
RELATED RESOURCES

snowflake

Publications about CTN-0027-A-2


 

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 2/2011 -- http://ctndisseminationlibrary.org/protocols/ctn0027a2.htm
info@ctndisseminationlibrary.org